The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...

Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public ...

In the whirlpool of broken narratives, post-truth dissonances, and chaos, every inch of newspaper space taken up by absurdity is wasted space.

If the 118th Congress does not reauthorize the farm bill, it will be incumbent upon the 119 th Congress to pass an updated ...

The post-Consolidation Common Shares are expected to commence trading on the Toronto Stock Exchange (“ TSX ”) and the Nasdaq at market open on January 29, 2025. The post-Consolidation Common Shares ...

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology ...

Learn more about whether Bio-Rad Laboratories, Inc. or Medpace Holdings, Inc. is a better investment based on AAII's A+ ...

W hether you're looking to improve and scale your existing business, starting a new venture or expanding into new markets, this comprehensive list of trusted firms, organisations and services will ...

Q4 2024 Earnings Conference Call January 29, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP of IRRainer Blair ...

"Mission Possible" by Swami Subramanian and Aparajithan Srivathsan suggests using modern technology to achieve Universal ...

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...